Dexamethasone intravitreal implant therapy for retinal vein occlusion macular oedema and conversion to ranibizumab in clinical practice
Ophthalmologica Oct 29, 2017
Balal S, et al. - Researchers performed an evaluation of outcomes in retinal vein occlusions (RVOs) for multiple repeat dexamethasone (DEX) injections and for conversion from DEX to ranibizumab. Based on the study, they supported using ranibizumab in eyes previously treated with DEX. Findings, in addition, provided long-term efficacy and safety data for multiple DEX injection.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
